Annette Langer-Gould to Interferon-beta
This is a "connection" page, showing publications Annette Langer-Gould has written about Interferon-beta.
Connection Strength
1.176
-
Immunomodulatory agents and risk of postpartum multiple sclerosis relapses. Perm J. 2014; 18(1):9-13.
Score: 0.476
-
Safety of potential breast milk exposure to IFN-ß or glatiramer acetate: One-year infant outcomes. Neurol Neuroimmunol Neuroinflamm. 2020 07; 7(4).
Score: 0.185
-
Pregnancy and Family Planning in Multiple Sclerosis. Continuum (Minneap Minn). 2019 Jun; 25(3):773-792.
Score: 0.173
-
Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis--Reply. JAMA Neurol. 2016 Apr; 73(4):480-1.
Score: 0.139
-
Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry. Mult Scler. 2016 05; 22(6):801-9.
Score: 0.138
-
Strategies for managing the side effects of treatments for multiple sclerosis. Neurology. 2004 Dec 14; 63(11 Suppl 5):S35-41.
Score: 0.064